Antibody dependent enhancement: Unavoidable problems in vaccine development.

Antibody-dependent infection enhancement Coronavirus Vaccine

Journal

Advances in immunology
ISSN: 1557-8445
Titre abrégé: Adv Immunol
Pays: United States
ID NLM: 0370425

Informations de publication

Date de publication:
2021
Historique:
entrez: 17 10 2021
pubmed: 18 10 2021
medline: 29 10 2021
Statut: ppublish

Résumé

In some cases, antibodies can enhance virus entry and replication in cells. This phenomenon is called antibody-dependent infection enhancement (ADE). ADE not only promotes the virus to be recognized by the target cell and enters the target cell, but also affects the signal transmission in the target cell. Early formalin-inactivated virus vaccines such as aluminum adjuvants (RSV and measles) have been shown to induce ADE. Although there is no direct evidence that there is ADE in COVID-19, this potential risk is a huge challenge for prevention and vaccine development. This article focuses on the virus-induced ADE phenomenon and its molecular mechanism. It also summarizes various attempts in vaccine research and development to eliminate the ADE phenomenon, and proposes to avoid ADE in vaccine development from the perspective of antigens and adjuvants.

Identifiants

pubmed: 34656289
pii: S0065-2776(21)00029-8
doi: 10.1016/bs.ai.2021.08.003
pmc: PMC8438590
pii:
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-133

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Front Immunol. 2020 Feb 26;11:334
pubmed: 32174923
Virol Sin. 2018 Jun;33(3):249-260
pubmed: 29761267
J Infect Dis. 1995 Sep;172(3):855-8
pubmed: 7658082
Immunol Rev. 2015 Nov;268(1):340-64
pubmed: 26497532
J Gen Virol. 2016 Dec;97(12):3280-3290
pubmed: 27902333
PLoS One. 2011;6(12):e28721
pubmed: 22220194
BMC Immunol. 2021 Jan 9;22(1):5
pubmed: 33421988
Chem Sci. 2019 Jan 28;10(11):3271-3280
pubmed: 30996912
J Infect Dis. 2009 Dec 15;200(12):1893-900
pubmed: 19911991
Virology. 1999 Jul 20;260(1):84-8
pubmed: 10405359
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3840-5
pubmed: 16497831
Lancet Infect Dis. 2010 Oct;10(10):712-22
pubmed: 20883967
J Exp Med. 1977 Jul 1;146(1):218-29
pubmed: 195000
Cell. 2021 Aug 5;184(16):4203-4219.e32
pubmed: 34242577
Emerg Microbes Infect. 2018 Dec 1;7(1):198
pubmed: 30504926
J Virol. 2005 Mar;79(5):2678-88
pubmed: 15708987
EBioMedicine. 2020 Apr;54:102738
pubmed: 32305868
Vaccine. 2000 Nov 22;19(7-8):982-91
pubmed: 11115725
Microbes Infect. 2020 Oct;22(9):405-406
pubmed: 32590062
Emerg Microbes Infect. 2019;8(1):516-530
pubmed: 30938227
Front Immunol. 2020 Jun 16;11:1055
pubmed: 32655548
Free Radic Biol Med. 2017 Jan;102:149-161
pubmed: 27908781
NPJ Vaccines. 2017 Jul 6;2:18
pubmed: 29263874
Antibodies (Basel). 2019 Apr 25;8(2):
pubmed: 31544836
PLoS Pathog. 2016 Dec 30;12(12):e1006139
pubmed: 28036370
J Immunol. 1990 Apr 15;144(8):3183-6
pubmed: 2139079
Nature. 2020 Aug;584(7821):353-363
pubmed: 32659783
Biochemistry. 2015 May 19;54(19):2931-42
pubmed: 25926001
Nat Med. 2009 Jan;15(1):34-41
pubmed: 19079256
Trends Microbiol. 2016 Apr;24(4):284-293
pubmed: 26747581
Sci Rep. 2017 Jan 13;7:40923
pubmed: 28084461
Science. 2020 Jul 3;369(6499):77-81
pubmed: 32376603
J Virol. 2014 Jul;88(14):8102-15
pubmed: 24807719
Int J Biol Macromol. 2019 Oct 1;138:198-206
pubmed: 31284005
Immunol Cell Biol. 2004 Oct;82(5):497-505
pubmed: 15479435
PLoS Negl Trop Dis. 2020 Sep 4;14(9):e0008602
pubmed: 32886656
J Infect Dis. 2007 Nov 15;196 Suppl 2:S347-56
pubmed: 17940970
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30830861
Microbes Infect. 2020 Mar;22(2):72-73
pubmed: 32092539
Int J Mol Sci. 2017 Dec 25;19(1):
pubmed: 29295568
J Virol. 2005 Jun;79(12):7819-26
pubmed: 15919935
Nat Rev Microbiol. 2004 Oct;2(10):789-801
pubmed: 15378043
J Gene Med. 2021 Feb;23(2):e3297
pubmed: 33217097
Biochem Biophys Res Commun. 2014 Aug 22;451(2):208-14
pubmed: 25073113
PLoS Negl Trop Dis. 2010 Dec 21;4(12):e924
pubmed: 21200427
J Med Virol. 1987 Jun;22(2):163-7
pubmed: 2440986
PLoS Negl Trop Dis. 2018 Aug 9;12(8):e0006685
pubmed: 30092029
Am J Trop Med Hyg. 1988 Mar;38(2):411-9
pubmed: 3354774
Cell. 2020 May 28;181(5):1004-1015.e15
pubmed: 32375025
Nat Rev Immunol. 2014 Feb;14(2):94-108
pubmed: 24445665
Appl Microbiol Biotechnol. 2015 Nov;99(22):9685-98
pubmed: 26219500
Virology. 1993 Mar;193(1):329-39
pubmed: 8438574
PLoS Pathog. 2019 Apr 18;15(4):e1007640
pubmed: 30998804
Cell Rep. 2020 Jun 2;31(9):107725
pubmed: 32426212
J Exp Med. 1998 Mar 2;187(5):675-83
pubmed: 9480977
Science. 2013 May 10;340(6133):701-6
pubmed: 23661752
Theranostics. 2019 Jul 9;9(16):4811-4826
pubmed: 31367259
Dev Comp Immunol. 2019 Jan;90:186-198
pubmed: 30273630
Nat Immunol. 2016 Sep;17(9):1102-8
pubmed: 27339099
Sci Rep. 2015 Jul 29;5:12616
pubmed: 26220099
Trends Microbiol. 2020 Mar;28(3):212-223
pubmed: 31744664
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12479-84
pubmed: 21746897
Nat New Biol. 1973 May 2;243(122):24-6
pubmed: 17319077
PLoS Pathog. 2010 Feb 12;6(2):e1000790
pubmed: 20168989
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7852-7
pubmed: 27354515
R Soc Open Sci. 2020 Apr 15;7(4):191749
pubmed: 32431874
Virology. 1990 Apr;175(2):600-4
pubmed: 2327077
Nat Rev Drug Discov. 2020 Apr;19(4):239-252
pubmed: 32060419
Clin Transl Immunology. 2016 Dec 16;5(12):e117
pubmed: 28090318
J Theor Biol. 2020 Oct 21;503:110379
pubmed: 32622789
J Immunol Res. 2016;2016:1459394
pubmed: 27274998
Viruses. 2019 Sep 06;11(9):
pubmed: 31489915
Vaccine. 2004 Nov 25;23(2):215-21
pubmed: 15531040
Mem Inst Oswaldo Cruz. 2019;114:e190098
pubmed: 31411310
J Gen Virol. 2015 Jul;96(Pt 7):1712-22
pubmed: 25752917
Curr Opin Virol. 2019 Jun;36:1-8
pubmed: 30844538
J Infect Dis. 2010 Mar 15;201(6):923-35
pubmed: 20158392
Virus Res. 2017 Feb 2;229:57-64
pubmed: 27939945
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3320
pubmed: 25412261
Viral Immunol. 1996;9(1):51-63
pubmed: 8733920
Cell Host Microbe. 2010 Sep 16;8(3):271-83
pubmed: 20833378
Immunity. 1999 Jan;10(1):21-8
pubmed: 10023767
Front Immunol. 2019 Dec 12;10:2920
pubmed: 31921179
Clin Vaccine Immunol. 2010 Dec;17(12):1829-35
pubmed: 20876821
J Virol. 2014 Aug;88(15):8468-78
pubmed: 24829340
J Exp Med. 1983 Jul 1;158(1):258-63
pubmed: 6864163
Immunity. 2005 Jul;23(1):41-51
pubmed: 16039578
AIDS. 1997 Jul;11(8):949-58
pubmed: 9223728
J Virol. 2006 Oct;80(20):10128-38
pubmed: 17005690
Nat Immunol. 2019 Oct;20(10):1291-1298
pubmed: 31477918
Emerg Infect Dis. 2005 Nov;11(11):1730-7
pubmed: 16318725
J Virol. 2011 Oct;85(20):10582-97
pubmed: 21775467
Cell Rep. 2016 Jun 28;16(1):232-246
pubmed: 27342126
Cell. 2021 Jun 24;184(13):3452-3466.e18
pubmed: 34139176
Viruses. 2020 Feb 08;12(2):
pubmed: 32046249
Nat Med. 2006 Aug;12(8):905-7
pubmed: 16862151
Immunity. 1997 Aug;7(2):273-82
pubmed: 9285411
Clin Exp Immunol. 1993 Apr;92(1):106-13
pubmed: 7682158
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2722-7
pubmed: 24550301
N Engl J Med. 2018 Jul 26;379(4):327-340
pubmed: 29897841
Arch Virol. 2021 Feb;166(2):389-402
pubmed: 33385245
ACS Infect Dis. 2016 May 13;2(5):361-76
pubmed: 27627203
J Interferon Cytokine Res. 2018 Feb;38(2):69-80
pubmed: 29443656
J Virol. 2003 Jul;77(13):7539-44
pubmed: 12805454
Res Vet Sci. 2016 Apr;105:47-52
pubmed: 27033907
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9422-7
pubmed: 17517625
Vaccine. 2013 Apr 18;31 Suppl 2:B209-15
pubmed: 23598484
Microbes Infect. 2020 May - Jun;22(4-5):158
pubmed: 32268188
J Clin Virol. 2012 Dec;55(4):289-95
pubmed: 22999801
Nat Rev Immunol. 2015 Dec;15(12):745-59
pubmed: 26603900
Vet Immunol Immunopathol. 2004 Dec 8;102(3):249-62
pubmed: 15507309
PLoS Negl Trop Dis. 2016 Aug 24;10(8):e0004921
pubmed: 27556644
J Infect Dis. 2018 Sep 22;218(9):1464-1473
pubmed: 29860306
Virology. 1967 Oct;33(2):250-61
pubmed: 6053142
Int Immunopharmacol. 2020 Sep;86:106717
pubmed: 32585611
J Infect Dis. 2008 Aug 15;198(4):516-24
pubmed: 18598189
J Trop Med. 2014;2014:901276
pubmed: 25580138
Int J Infect Dis. 2021 Feb;103:404-411
pubmed: 33352325
J Infect Dis. 2015 Sep 1;212(5):711-4
pubmed: 25732810
Front Cell Infect Microbiol. 2017 May 09;7:157
pubmed: 28536674
Viruses. 2019 Jan 08;11(1):
pubmed: 30626045
Cell. 2019 Feb 21;176(5):1026-1039.e15
pubmed: 30712865
Cell Rep. 2021 Feb 2;34(5):108699
pubmed: 33485405
mSphere. 2019 Sep 18;4(5):
pubmed: 31533998
Science. 2017 Jan 27;355(6323):395-398
pubmed: 28126818
Vaccine. 2006 Apr 12;24(16):3100-8
pubmed: 16494977
J Virol. 2020 Feb 14;94(5):
pubmed: 31826992
J Gen Virol. 2007 Feb;88(Pt 2):365-375
pubmed: 17251552

Auteurs

Lele Xu (L)

College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China.

Zhiqian Ma (Z)

College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China.

Yang Li (Y)

College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China.

Zhaoxia Pang (Z)

College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China.

Shuqi Xiao (S)

College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. Electronic address: xiaoshuqi@nwsuaf.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH